NCT02249247View on ClinicalTrials.gov

Effect of Treatment With BIIL 284 BS on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

577

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

August 31, 2002

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Low dose of BIIL 284 BS tablets

DRUG

Medium dose of BIIL 284 BS tablets

DRUG

High dose of BIIL 284 BS tablets

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY